Form 8-K Sana Biotechnology, Inc. For: Apr 18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Sana Biotechnology (SANA) Announces Resignation of Douglas Williams
April 18, 2024 5:06 PM EDTEffective April 18, 2024, Douglas Williams, Ph.D. resigned from his position as Executive Vice President and President, Research and Development of Sana Biotechnology (NASDAQ: SANA). Dr. Williams resigned voluntarily for personal reasons and not as a result of any disagreement with the Company.
... More
